Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials
As you can see monthly titration except for the 6mg group, which was actually 3mg for most of the trial, then at week 32 they increased the dose to 6mg and continued on until week 48 which is a weird choice to say the least
The approval of GLP-1 RAs, starting with exenatide in 2005, followed by semaglutide and oral formulations, has expanded treatment options for patients seeking effective, long-term solutions for T2DM and obesity (15)
Stevens, A
US$ 21.46
US$ 27.15
US$ 20.54
US$ 20.41
US$ 22.91
US$ 26.52
